The War Room

Recurrence and metastasis remain among cancer care’s hardest unresolved problems. In this episode, Mohan examines whether a blood draw can yield a more actionable view of a changing tumour.

He contrasts tissue biopsy and liquid biopsy before turning to circulating tumour cells: rare cells shed from solid tumours that may carry information DNA fragments alone cannot provide. OneCell’s proposed “cell biopsy” seeks to capture those cells—roughly one among a billion—then combine imaging, DNA, RNA, proteins and AI analysis.

Mohan explains why the aim is not simply to count cells, but to help oncologists interpret treatment response, resistance and cancer’s evolution over time. The conversation follows the practical path as well: OncoInsight’s integrated ctDNA and single-cell workflow, use in biopharma studies and companion diagnostics, and the evidence, regulatory and reimbursement work still ahead.

At stake is an ambitious proposition: earlier, less invasive monitoring for cancer survivors and a more affordable route to precision oncology.

A founder whose education began in a village barn turned repeated product setbacks into a protein-led healthy-snacking p

What does a responsible exit look like when a brand’s value was built by more than its founders? In this episode of The War Room, the founder of Natural and RightBite Max Protein traces the decision to sell a profitable healthy-snacking business to Zydus Wellness—and the test he used to judge the deal.

He explains how a simple customer insight changed the company’s ambition: gym-goers were eating protein bars as snacks, opening a wider market than post-workout nutrition. That shift made outside capital from Rabo India Agri Fund worth taking, alongside an ESOP intended to share eventual upside across the organisation.

Years later, growth from roughly ₹30 crore to ₹150 crore brought a new question: pursue another demanding scale-up or make room for a different chapter after 60. The conversation follows the difficult buyer search, the brand equity and distribution that made the business attractive, and a four-stakeholder framework spanning the brand, employees, shareholders and partners.

At the centre is an additional ₹5 crore employee pool reaching more than 250 people, with payouts extending beyond payroll. It is a story of product taste, profitable growth and what it takes to sell without leaving people behind.

How does a founder turn a blocked sweetener business and a nutrition bar nobody wants into a healthy-snacking platform? In this episode of The War Room, he traces the path from a childhood in a village near Nagpur—without a school, post office, or electricity—to agriculture, Silicon Valley product work, and a return to India.

He explains why Naturals began with Stevia, what happened when regulation halted that plan, and why RightBite’s early “healthy chocolate” pitch failed at both ₹15 and ₹5. Rather than retreat, he listens for a clearer consumer job: a snack with a functional purpose.

That shift reshapes the business. Distinct benefits for gym-goers, calorie-conscious consumers, and women’s nutrition lead to repeat purchase; a lesson about bars eaten alongside protein shakes helps define Max Protein. He then unpacks the move from protein bars to chips, cookies, granola, peanut butter, and plant protein—designed around protein, fibre, satiety, and sustained energy.

Finally, he reflects on the completed Zydus Wellness transaction and why category-building ambition now needs partners, resources, and expertise to grow.

How does a founder turn a product that will not move into a category consumers can finally see? In this episode, he traces a path from a village near Nagpur—where his early education began without basic infrastructure—to agriculture, computer science, Silicon Valley, and back to India to build products.

His first health-food mission was rooted in farmer income: Stevia promised a new crop and a consumer sweetener, until an approval roadblock intervened. The next attempt, RightBite nutrition bars priced for mass retail, exposed another hard truth. In Kirana stores, shoppers saw chocolate, not a health proposition.

He explains the shift that changed the business: put the functional benefit on the pack, identify a specific need, and follow actual consumer behaviour. That discipline led from workout bars to Max Protein, and from a single product to a broader healthy-snack platform spanning protein-and-fibre foods.

The conversation closes on growth, partnership, and the larger ambition behind the next chapter: creating healthier snack occasions at scale.

When Naturals had grown from a niche protein-bar business into a healthy-snacking brand, its founder faced the question that changes many profitable companies: how to fund the next stage while ensuring those who built it could share in the success.

In this episode of The War Room, he traces the consumer insight that broadened the brand’s market, the capital pressure behind the decision to take outside investment, and the decision to build employee ownership into the company before bringing in Rabo. After revenue rose from roughly ₹30 crore to ₹150 crore and the fund needed an exit, he had to decide whether a new investor or a strategic buyer could take the brand towards ₹1,000 crore.

He explains why Zydus Wellness was selected: not simply for scale, but for a plan to preserve independence, support existing distributors and suppliers, and protect the brand’s character. At the heart of the deal is a hard-edged conviction about shared upside: an additional ₹5 crore for employee distribution and payouts structured above the investor per-share price. The conversation closes on stewardship, succession, and Smita’s role in shaping the taste and design behind the brands.

How does a fledgling Stevia experiment morph into India’s largest home-grown protein-bar brand and land a blockbuster strategic buy-out? In this War Room episode, founder Vijay shares the decisions that powered Natural’s Max Protein from a kitchen-table idea to a ₹150-crore healthy-snacking powerhouse. He opens with the near-empty bank balance that forced a pivot from sweetener sachets to high-protein bars, then unpacks why he turned down early venture money until repeat customers proved the category. Listeners hear the consumer insight that moved the bar from gym racks to supermarket snack aisles, and the radical ESOP plan that handed equity to everyone from vice-presidents to office boys. Finally, Vijay walks through the four competing term sheets that appeared in one frantic fortnight and explains why a 100 % sale to Zydus Wellness – at a higher per-share price for employees than investors – felt like the right next chapter. A masterclass in disciplined scaling, culture-first ownership and timing the perfect exit.

Vijay Uttarwar began selling a protein bar to gym rats from a single Mumbai storefront. Fifteen years later, Max Protein sits in every Indian supermarket aisle and has just been acquired in a ₹450-crore cash deal by pharma giant Zydus Wellness. In this episode of The War Room, the veteran founder unpacks the checkpoints that turned a niche supplement into a ₹150-crore healthy-snacking brand—and why he waited until revenue hit ₹30 crore before taking a rupee of outside money.

Listeners hear the inside math behind a 5× growth spurt fuelled by Rabo’s agri-fund, the near-miss emotions of negotiating four simultaneous term sheets during a funding winter, and the radical decision to grant ESOPs to every employee—from vice-presidents to office boys. Vijay explains how he convinced Zydus to preserve jobs, funnel ₹5 crore extra to staff and suppliers, and let his wife Smita keep steering flavour innovation.

Whether you’re a consumer-brand operator, early employee, or investor hunting fair-return stories, this conversation offers a masterclass on aligning mission, money and legacy.

The War Room tracks the 20-year journey of Right Bite Max Protein’s founder, who turned a home-grown protein bar into a ₹150-crore healthy-snacking force—and then sold 100 percent of it to Zydus Wellness. Listeners hear why he refused venture capital for years, the consumer insight that shifted the bar from gym supplement to everyday snack, and how a values-aligned cheque from Rabo turbo-charged revenue five-fold. The conversation peels back the mechanics of a broad ESOP that gave 250 employees real skin in the game, the gruelling beauty parade that produced four competing term sheets, and the stakeholder-first negotiations that guaranteed no layoffs and a ₹5-crore employee bonus pool. Along the way, the veteran founder wrestles with turning 60, handing the reins to a strategic giant, and crediting his wife Smita for every flavour that flew off the shelf. It’s a masterclass in timing your raise, sharing the upside, and exiting on your own terms.

The War Room sits down with RiteBite Max Protein founder Vijay Kandpal to unpack a journey that began with a rented apartment and finished with a headline-grabbing strategic sale. Kandpal recalls scraping together personal savings and rental income to push revenues past ₹30 crore, keeping less money in his Mumbai bank than in the US account he left behind. A chance insight—customers were snacking, not ‘supplementing’—unlocked the far larger healthy-snacking market and convinced him to finally accept venture capital. With Rabo’s funds he widened distribution, grew five-fold to ₹150 crore and, unusually for Indian FMCG, granted stock options to every employee: office boys, factory operators and VPs alike. When both he and his investors searched for an exit, Kandpal chose Zydus Wellness, structuring a 100 percent buyout that preserves jobs and sets aside an extra ₹5 crore so more than 250 staff can cash life-changing cheques. It’s a masterclass in capital discipline, brand positioning and people-first deal-making—told by the man who lived every trade-off.